<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00832702</url>
  </required_header>
  <id_info>
    <org_study_id>IRB# 14906</org_study_id>
    <secondary_id>5R01HL090957</secondary_id>
    <nct_id>NCT00832702</nct_id>
  </id_info>
  <brief_title>Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction</brief_title>
  <official_title>Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cedars-Sinai Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cedars-Sinai Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study is designed to investigate the approaches to noninvasive detection and&#xD;
      assessment of coronary vascular dysfunction in women by comparing the testing results from&#xD;
      the invasive standard care diagnostic procedure Angiogram and from the additional noninvasive&#xD;
      diagnostic procedure CMR Imaging. The investigators want to specifically study 375 female&#xD;
      patients who have signs or symptoms suggestive of heart disease but don't have obstructive&#xD;
      coronary artery disease. Two study sites (Cedars-Sinai Medical Center and University of&#xD;
      Florida) are recruiting participants.&#xD;
&#xD;
      The standard of care procedures include demographics, review of recent clinical symptoms,&#xD;
      review of medications being taken, a physical exam, pre-angiogram blood collection, chest&#xD;
      x-ray, ECG and heart angiogram. The research procedures for this study are the cold pressor&#xD;
      testing, blood/urine collection, health questionnaire, the post-angiogram ECG and cardiac&#xD;
      MRI.&#xD;
&#xD;
      Patients will be asked to undergo heart angiogram testing to test for abnormalities in their&#xD;
      heart arteries. If the heart angiogram shows that the patients do not have blockages in major&#xD;
      heart arteries, then the patients will have coronary flow reserve measurement test (as part&#xD;
      of the heart angiogram) to determine whether the patients have abnormally functioning of the&#xD;
      small heart arteries. This test will be performed by infusing the three drugs: adenosine,&#xD;
      acetylcholine and nitroglycerin. The three drugs are naturally occurring substances and have&#xD;
      been used for routine heart angiograms.&#xD;
&#xD;
      Cardiac Magnetic Resonance (CMR) imaging may help us more easily and non-invasively detect&#xD;
      abnormalities in the inner layer of the heart muscle resulting from the abnormal function of&#xD;
      the heart arteries. All the 375 participants will undergo baseline CMR imaging test and a&#xD;
      subgroup of 200 participants will undergo a second CMR imaging test at their at least 1-year&#xD;
      followup visit.&#xD;
&#xD;
      Patients will be followed up using phone questionnaires at 6 weeks, 6 months for 5 years, and&#xD;
      than annually for 20 years thereafter. Other procedures in this study include obtaining&#xD;
      informed consent, review of demographics, physical examination, ECG, blood and urine tests,&#xD;
      clinical symptoms, medications, questionnaires, etc. The core laboratories include Blood,&#xD;
      Lipoprotein, Chemistry Core Lab, Reproductive Hormone Core Lab, Inflammatory Marker Core Lab,&#xD;
      Oxidative Stress Core Lab, and Angiographic Core Lab. Additionally, GCRC at Cedars Sinai will&#xD;
      process, store and ship samples as needed/required.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      See Brief Summary above.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 17, 2008</start_date>
  <completion_date type="Anticipated">August 31, 2050</completion_date>
  <primary_completion_date type="Actual">September 15, 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Abnormal cardiac magnetic resonance imaging (CMRI)</measure>
    <time_frame>30 years</time_frame>
    <description>Subjects will be contacted at 6-week followup and then annually indefinitely.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Resource utilization and costs</measure>
    <time_frame>30 years</time_frame>
    <description>Annual costs will include cardiovascular hospitalizations, coronary revascularizations and angiography, outpatient testing, and visits to generalists, specialists, nurse practitioners/ physician's assistants, or community clinics.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Chest Pain Symptoms</measure>
    <time_frame>30 years</time_frame>
    <description>Detailed information on chest pain symptoms will include the traditional angina questionnaire and the WISE female angina questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Outcomes</measure>
    <time_frame>30 years</time_frame>
    <description>Quality of life and functional capacity will be collected using the standard instruments of SAQ and DASI</description>
  </secondary_outcome>
  <enrollment type="Anticipated">433</enrollment>
  <condition>Cardiovascular Disease</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiac MRI</intervention_name>
    <description>CMRI provides unique clinical utilities including excellent soft tissue characterization and contrast, three-dimensionality, quantitation of blood flow, and overall superior temporal and spatial resolution to image vascular and myocardial abnormalities.</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sample will be collected for future genetic studies to better understand heart artery&#xD;
      disease by identifing genetic factors that contribute to heart artery disorders, and for&#xD;
      extraction and creation of cell lines.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women undergoing clinically-ordered coronary angiography for suspected ischemia will be&#xD;
        recruited. See the inclusion and exclusion criteria for details.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Symptomatic angina or anginal equivalent;&#xD;
&#xD;
          2. Aged 18 years or older;&#xD;
&#xD;
          3. No obstructive CAD at coronary angiography (performed within the previous 24 months).&#xD;
&#xD;
          4. Competent to give informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Obstructive CAD ≥ 50% luminal diameter stenosis in ≥ 1 epicardial coronary artery,&#xD;
&#xD;
          2. Acute coronary syndrome (defined by the ACC/AHA criteria, Braunwald 2000),&#xD;
&#xD;
          3. Primary valvular heart disease clearly indicating the need for valve repair or&#xD;
             replacement;&#xD;
&#xD;
          4. Patients with concurrent cardiogenic shock or requiring inotropic or intra-aortic&#xD;
             balloon support;&#xD;
&#xD;
          5. Prior or planned percutaneous coronary intervention or CABG,&#xD;
&#xD;
          6. Acute MI;&#xD;
&#xD;
          7. Prior non-cardiac illness with an estimated life expectancy &lt; 4 years;&#xD;
&#xD;
          8. Unable to give informed consent;&#xD;
&#xD;
          9. Chest pain with a non-ischemic etiology (e.g.,pericarditis, pneumonia, esophageal&#xD;
             spasm);&#xD;
&#xD;
         10. Contraindications to CMRI (e.g., AICD, pacemaker, untreatable claustrophobia or known&#xD;
             angio-edema).&#xD;
&#xD;
         11. Contraindications to adenosine or Regadenoson (Lexiscan)&#xD;
&#xD;
         12. Women with intermediate coronary stenoses (&gt; 20% but &lt; 50% luminal diameter stenosis&#xD;
             assessed visually at the time of angiography) will undergo clinically indicated IVUS&#xD;
             testing based on the judgment of the operator; those determined to have&#xD;
             flow-obstructing stenosis will be excluded from the overall study.&#xD;
&#xD;
         13. Participation in a research study that conflicts with the current WISE study.&#xD;
&#xD;
         14. Women with coronary stenosis ≥ 50% in any epicardial coronary artery, assessed&#xD;
             visually at the time of angiography, will not be included in the CRT subgroup.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>C. Noel Bairey Merz, MD, FACC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cedars-Sinai Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carl J Pepine, MD, MACC</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cedars-Sinai Barbra Streisand Women's Heart Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610-0277</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 28, 2009</study_first_submitted>
  <study_first_submitted_qc>January 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2009</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cedars-Sinai Medical Center</investigator_affiliation>
    <investigator_full_name>Noel Bairey Merz</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>Cardiac</keyword>
  <keyword>MRI</keyword>
  <keyword>Coronary Vascular Dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

